Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy

Publication | Closed Access

DOI

Citations

References

2008

Year

Sripal Bangalore, Franz H. Messerli, Jerome D. Cohen, Peter Bacher, Peter Sleight, Giuseppe Mancia, Peter R. Kowey, Qian Zhou, Annette Champion, Carl J. Pepine

American Heart Journal

ThrombosisCardiovascular DiseasePrior Myocardial InfarctionCardiovascular PharmacologyTreatment StrategyPharmacotherapyMedicineCardiologyInternational Verapamil Sr-trandolaprilAnesthesiologyMyocardial Infarction